Skip to main content
. 2023 May 8;32(1):40–48. doi: 10.5114/ppn.2023.127237

Table 1.

Main pharmacological and psychotherapeutic options for the treatment of eating disorders

Anorexia nervosa Bulimia nervosa Binge eating disorder
Adults Children and adolescents Adults Children and adolescents Adults Children and adolescents
Pharmacology Fluoxetine,
citalopram,
sertraline,
olanzapine,
aripiprazole
Olanzapine,
risperidone,
quetiapine,
aripiprazole
Fluoxetine*,
citalopram,
sertraline,
fluvoxamine,
topiramate,
naltrexone,
ondastentron
Fluoxetine LDX**, topiramate LDX
Psychotherapy CBT-E SSCM, MANTRA, CRT CREST FBT, adolescent- focused psychotherapy, CBT, systemic family therapy CBT-BN, ITP, PDT FBT, CBT CBT, ITP, DBT, BWL CBT, ITP, DBT

CBT-E - cognitive behaviour therapy-enhanced, SSCMI - Specialist Supportive Clinical Management, MANTRA - Maudsley Anorexia Nervosa Treatment for Adults, CRT - cognitive remediation therapy, CREST - cognitive remediation and emotion skills training, AN-EXRP - exposure and response prevention for anorexia nervosa, ACT - acceptance and commitment therapy, DBT - dialectical behavioral therapy, FBT - family-based treatment, CBT-BN - cognitive-behavioral therapy for bulimia nervosa, ITP - interpersonal psychotherapy, PDT - psychodynamic psychotherapy, BWL - behavioral weight loss, LDX - lisdexafetamine *Fluoxetine is the only approved medication for bulimia nervosa in the adult population.

**

Lisdexafetamine is the only approved medication for binge eating in the adult population.